225 related articles for article (PubMed ID: 17229875)
1. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.
Mujoomdar A; Austin JH; Malhotra R; Powell CA; Pearson GD; Shiau MC; Raftopoulos H
Radiology; 2007 Mar; 242(3):882-8. PubMed ID: 17229875
[TBL] [Abstract][Full Text] [Related]
2. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
3. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
[TBL] [Abstract][Full Text] [Related]
5. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location.
Kotoulas CS; Foroulis CN; Kostikas K; Konstantinou M; Kalkandi P; Dimadi M; Bouros D; Lioulias A
Lung Cancer; 2004 May; 44(2):183-91. PubMed ID: 15084383
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
Cho S; Song IH; Yang HC; Kim K; Jheon S
Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
9. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
10. Risk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients.
Srivastava G; Rana V; Wallace S; Taylor S; Debnam M; Feng L; Suki D; Karp D; Stewart D; Oh Y
J Thorac Oncol; 2009 Mar; 4(3):333-7. PubMed ID: 19190519
[TBL] [Abstract][Full Text] [Related]
11. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
[TBL] [Abstract][Full Text] [Related]
12. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
13. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
14. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.
Rice SR; Molitoris JK; Vyfhuis MAL; Edelman MJ; Burrows WM; Feliciano J; Nichols EM; Suntharalingam M; Donahue J; Carr SR; Friedberg J; Badiyan S; Simone CB; Feigenberg SJ; Mohindra P
Clin Lung Cancer; 2019 Jan; 20(1):e107-e114. PubMed ID: 30337268
[TBL] [Abstract][Full Text] [Related]
15. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer.
Yuan S; Meng X; Yu J; Mu D; Chao KS; Zhang J; Zhong W; Yu Y; Wang J; Sun X; Yang G; Wang Y
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):727-34. PubMed ID: 17293231
[TBL] [Abstract][Full Text] [Related]
16. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.
Lee PC; Port JL; Korst RJ; Liss Y; Meherally DN; Altorki NK
Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407
[TBL] [Abstract][Full Text] [Related]
18. Results of a surgical resection for patients with stage IV non--small-cell lung cancer.
Hanagiri T; Takenaka M; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Tanaka F
Clin Lung Cancer; 2012 May; 13(3):220-4. PubMed ID: 22138036
[TBL] [Abstract][Full Text] [Related]
19. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
20. [Stage IB non-small cell lung cancer: impact of the number of lymph nodes examined on survival].
Cerón J; Peñalver JC; Jordá C; Padilla J
Arch Bronconeumol; 2009 Feb; 45(2):87-91. PubMed ID: 19232270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]